Publications

5532 Results

CA-125 concentration 8 weeks after treatment initiation independently predicts survival in patients with advanced epithelial ovarian cancer: A Southwest Oncology Group (SWOG) study.

Authors
PY Liu;DS Alberts;M Federico;EV Hannigan;DJ Garcia;ML Rothenberg;RT Dorr
Journal / Conference
ASCO 14:266(#735)
Year
1995
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report.

Authors
CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;CM Tangen;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard
Journal / Conference
Annals of Internal Medicine 122(5):321-326
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR-/efflux+ and MDR1+/efflux- cases

Authors
CP Leith;IM Chen;KJ Kopecky;FR Appelbaum;DR Head;JE Godwin;JK Weick;CL Willman
Journal / Conference
Blood 86(6):2329-2342
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9031

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: A Southwest Oncology Group study.

Authors
FL Meyskens Jr;KJ Kopecky;CW Taylor;RD Noyes;RJ Tuthill;EM Hersh;LG Feun;JH Doroshow;LE Flaherty;VK Sondak
Journal / Conference
Journal of the National Cancer Institute 87(22):1710-1713
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8642

A phase II trial of piroxantrone in advanced ovarian carcinoma after failure of platinum-based chemotherapy: Southwest Oncology Group Study 8904

Authors
KS Albain;PY Liu;A Hantel;EA Poplin;RV O'Toole;JL Wade III;AM Maddox;DS Alberts
Journal / Conference
Gynecologic Oncology 57:407-411
Year
1995
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8904

Evaluation of 96-hour infusion fluorouracil plus cisplatin in combination with alpha interferon for patients with advanced squamous cell carcinoma of the head and neck. A Southwest Oncology Group study.

Authors
M Hussain;J Benedetti;RE Smith;GI Rodriguez;DE Schuller;JF Ensley
Journal / Conference
Cancer 76(7):1233-1237
Year
1995
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-9062

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805

Authors
KS Albain;VW Rusch;JJ Crowley;TW Rice;AT Turrisi;JK Weick;VA Lonchyna;CA Presant;RJ McKenna;DR Gandara;H Fosmire;SA Taylor;KJ Stelzer;KR Beasley;RB Livingston
Journal / Conference
Journal of Clinical Oncology 13(8):1880-1892
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-8805

Design and conduct of a double-blind, placebo-controlled trial of daunorubicin and cytarabine wiht our without granulocyte colony-stimulating factor in elderly patients with acute myeloid leukemia: a Southwest Oncology Group Study.

Authors
J Godwin
Journal / Conference
Journal of the National Cancer Institute Monography 19:31-35
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Southwest Oncology Group strategies in prostatic carcinoma

Authors
ED Crawford;M Hussain;EP DeAntoni;IM Thompson;MA Eisenberger;B Blumenstein;CA Coltman Jr
Journal / Conference
Seminars in Surgical Oncology 11:60-64
Year
1995

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study

Authors
CG Leichman;TR Fleming;FM Muggia;CM Tangen;B Ardalan;JH Doroshow;FJ Meyers;RF Holcombe;GR Weiss;A Mangalik;JS Macdonald
Journal / Conference
Journal of Clinical Oncology 13(6):1303-1311
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8905